Wanbangde Pharmaceutical Holding Group Co.,ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Wanbang Pharmaceutical Holdings Group Co., Ltd. was founded in 1970 and is a high-tech enterprise specializing in the research and development, production, and sales of modern Chinese medicine, chemical raw materials, and preparations. It is the core enterprise of the listed company Wanbang Pharmaceutical Holdings Group Co., Ltd. (stock code: 002082). Taking building a "Healthy China" as a benchmark, Wanbang Pharmaceutical Group has always adhered to the path of integrating industry, academia, and research. It has a mature technology transformation platform, and has "National Academician Expert Workstation", "Zhejiang University Wanbang Traditional Chinese Medicine Modernization Joint Research Center", "China Pharmaceutical University Wanbang Drug Joint Research and Development Center", "Provincial Enterprise Research Institute of Cardiovascular and Cerebrovascular Drugs", and "Provincial Enterprise Technology Center" Honorary qualifications such as "The First Medical Research Enterprise Collaborative Innovation Alliance for Medical Products in China - Ginkgo Leaf Drop Pill Medical Research Enterprise Collaborative Innovation Alliance", participated in the drafting of multiple national pharmacopoeia standards, obtained 30 patents, including 23 invention patents and 3 international patents. The company's registered trademark has been recognized as a well-known trademark in China. Currently, Wanbang Pharmaceutical Group has formed a product pattern characterized by natural plant drugs, with cardiovascular, cerebrovascular, and nervous system drugs as the main products, supplemented by respiratory and other fields of medication. The products cover multiple treatment fields such as cardiovascular, cerebrovascular, nervous system, respiratory, and digestive system diseases, and have the world's first Huperzine A raw material and injection The core products of the two major intellectual property rights of Ginkgo Leaf Dropping Pills, an exclusive protected variety of traditional Chinese medicine in China. |
| Headquarter | Huzhou |
| Establish Date | 3/31/1999 |
| Listed Code | 002082.SZ |
| Listed Date | 11/20/2006 |
| Chairman | Zhao Shouming. |
| CEO | Zhao Shouming. |
| Website | www.wepon.com.cn |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
